Feb 13, 2024 01:15AM
Apr 18, 2023 01:15AM
Jan 11, 2023 01:15AM
Oct 24, 2022 01:15AM
Oct 13, 2022 01:15AM
Aug 16, 2022 01:15AM
Jun 28, 2022 01:15AM Basilea announces positive results of phase 3 ERADICATE study with ceftobiprole in Staphylococcus aureus bacteremia (SAB)
Mar 8, 2022 01:15AM
Feb 15, 2022 01:15AM
Jan 11, 2022 01:15AM
Jan 6, 2022 01:15AM
Dec 17, 2021 01:15AM
Nov 16, 2021 01:15AM
Aug 17, 2021 01:15AM Basilea reports strong financial results for half-year 2021 with significantly increased cash flow from marketed brands and increases 2021 full-year guidance
Aug 16, 2021 01:15AM
Jul 29, 2021 01:15AM
Feb 16, 2021 01:15AM
Aug 11, 2020 01:15AM
May 28, 2020 01:15AM
Jan 8, 2020 01:15AM
Aug 6, 2019 01:15AM Basilea announces positive results of phase 3 TARGET study with antibiotic ceftobiprole in the treatment of acute bacterial skin and skin structure infections (ABSSSI)
Apr 12, 2019 01:15AM
Feb 19, 2019 01:16AM
Jan 4, 2019 01:16AM
Aug 14, 2018 01:16AM
Aug 9, 2018 01:16AM
Apr 17, 2018 01:16AM
Feb 27, 2018 01:16AM Basilea reports significantly improved financial results in 2017
Feb 23, 2018 01:16AM
Dec 21, 2017 01:16AM
Dec 1, 2017 01:22AM
Aug 10, 2017 01:18AM
Jun 14, 2017 01:16AM
Jun 13, 2017 01:19AM
Apr 27, 2017 12:33PM Basilea shareholders approve all resolutions proposed by the Board of Directors at the Ordinary General Meeting of Shareholders
Apr 21, 2017 01:17AM
Feb 20, 2017 01:16AM

325,264 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All